Suresh Kumar

Dr. Suresh Kumar

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2021 in JCI Insight
Verified
Journal Article
Open access
PDF file
WHWenquan Hu
Wenquan Hu
ZLZhong Liu
Zhong Liu
VSValerie Salato
Valerie Salato
PNPaula E. North
Paula E. North
JBJoyce Ellen Bischoff
Joyce Ellen Bischoff
QMQing Miao
Qing Miao
Infantile hemangioma is a vascular tumor characterized by the rapid growth of disorganized blood vessels followed by slow spontaneous involution. The underlying molecular mechanisms that regulate hemangioma proliferation and involution still are not well elucidated. Our previous studies reported that NOGOB receptor (NGBR), a transmembrane protein, is required for the translocation of prenylated RAS from the cytosol to the plasma membrane and promotes RAS activation. Here, we show that NGBR was highly expressed in the proliferating phase of infantile hemangioma, but its expression decreased in the involuting phase, suggesting that NGBR may have been involved in regulating the growth of proliferating hemangioma. Moreover, we demonstrate that NGBR knockdown in hemangioma stem cells (HemSCs) attenuated growth factor–stimulated RAS activation and diminished the migration and proliferation of HemSCs, which is consistent with the effects of RAS knockdown in HemSCs. In vivo differentiation assay further shows that NGBR knockdown inhibited blood vessel formation and adipocyte differentiation of HemSCs in immunodeficient mice. Our data suggest that NGBR served as a RAS modulator in controlling the growth and differentiation of HemSCs.

16 August 2021 in IEEE Journal of Translational Engineering in Health and Medicine
Verified
Journal Article
Open access
FFFarnaz H. Foomani
Farnaz H. Foomani
JJJason A. Jarzembowski
Jason A. Jarzembowski
SMSoudeh Mostaghimi
Soudeh Mostaghimi
SMShima Mehrvar
Shima Mehrvar
SKSuresh Kumar
Suresh Kumar
MRMahsa Ranji
Mahsa Ranji
Background: Mitochondrial $\beta $ -oxidation of fatty acids is the primary energy source for the heart and carried out by Hydroxy Acyl-CoA Dehydrogenase (HADH) encoded trifunctional protein. Mutations in the genes encoding mitochondrial proteins result in functionally defective protein complexes that contribute to energy deficiencies, excessive reactive oxygen species (ROS) production, and accumulation of damaged mitochondria. We hypothesize that a dramatic alternation in redox state and associated mitochondrial dysfunction is the underlying cause of Fatty Acid Oxidation (FAO) deficiency mutant, resulting in heart failure. Mitochondrial co-enzymes, NADH and FAD, are autofluorescent metabolic indices of cells when imaged, yield a quantitative assessment of the cells’ redox status and, in turn, that of the tissue and organ. Method: We utilized an optical cryo-imager to quantitively evaluate the three-dimensional distribution of mitochondrial redox state in newborn rats’ hearts and kidneys. Redox ratio (RR) assessment shows that mitochondrial dysfunction is extreme and could contribute to severe heart problems and eventual heart failure in the mutants. Results: Three-dimensional redox ratio (NADH/FAD) rendering, and the volumetric mean value calculations confirmed significantly decreased cardiac RR in mutants by 31.90% and 12.32%, in renal mitochondrial RR compared to wild-type control. Further, histological assessment of newborn heart myocardial tissue indicated no significant difference in myocardial tissue architecture in both control and severe (HADHA e4−/− ) conditions. Conclusion: These results demonstrate that optical imaging can accurately estimate the redox state changes in newborn rat organs. It is also apparent that the FAO mutant’s heart tissue with a low redox ratio is probably more vulnerable to cumulative damages than kidneys and fails prematurely, contributing to sudden death.

12 August 2025 in Transplantation Proceedings
Verified
Journal Article
Closed access
JKJoohyun Kim
Joohyun Kim
SHSeung-Keun Hong
Seung-Keun Hong
ALAlice Lee
Alice Lee
SKSuresh Kumar
Suresh Kumar
MSMariko Suchi
Mariko Suchi
JPJong-In Park
Jong-In Park

16 September 2025 in EMBO Reports
Verified
Journal Article
Open access
SKSushil Kumar
Sushil Kumar
XJXuan Ji
Xuan Ji
HIHina Iqbal
Hina Iqbal
XGXiangnan Guan
Xiangnan Guan
BMBrittany Mis
Brittany Mis
RSRavi K Singh
Ravi K Singh
During prolonged starvation and exhaustive exercise, when there is low availability of carbohydrates, the liver breaks down fatty acids to generate ketone bodies, which are utilized by peripheral tissues as an alternative fuel source. The transcription factor MEF2D undergoes regulated alternative splicing in the postnatal period to produce a highly conserved, muscle specific MEF2Dα2 protein isoform. Here, we discover that compared to WT mice, MEF2Dα2 exon knockout (Eko) mice display reduced running capacity and muscle expression of all three ketolytic enzymes: BDH1, OXCT1, and ACAT1. MEF2Dα2 Eko mice consistently show increased blood ketone body levels in a tolerance test, after exercise, and when fed a ketogenic diet. Lastly, using mitochondria isolated from skeletal muscle, Eko mice show reduced ketone body utilization compared to WT mice. Collectively, our findings identify a new role for the MEF2Dα2 protein isoform in regulating skeletal muscle ketone body oxidation, exercise capacity, and systemic ketone body levels.

1 July 2023 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
SEShahram Eisa-Beygi
Shahram Eisa-Beygi
MHMeng-Ming Hu
Meng-Ming Hu
SKSuresh Kumar
Suresh Kumar
BJBrooke E. Jeffery
Brooke E. Jeffery
RCRoss F. Collery
Ross F. Collery
BLBrian A. Link
Brian A. Link
Background: The goal of this study was to identify and characterize cell-cell interactions that facilitate endothelial tip cell fusion downstream of BMP (bone morphogenic protein)-mediated venous plexus formation. Methods: High resolution and time-lapse imaging of transgenic reporter lines and loss-of-function studies were carried out to study the involvement of mesenchymal stromal cells during venous angiogenesis. Results: BMP-responsive stromal cells facilitate timely and precise fusion of venous tip cells during developmental angiogenesis. Conclusions: Stromal cells are required for anastomosis of venous tip cells in the embryonic caudal hematopoietic tissue.

27 May 2025 in Life
Verified
Journal Article
Open access
PDF file
DADayeong An
Dayeong An
AKAlison J Kriegel
Alison J Kriegel
SKSuresh Kumar
Suresh Kumar
HHHeather Anne Himburg
Heather Anne Himburg
BFBrian L. Fish
Brian L. Fish
EIEl-Sayed H Ibrahim
El-Sayed H Ibrahim
Radiation therapy (RT) plays a vital role in managing thoracic cancers, though it can lead to adverse effects, including significant cardiotoxicity. Understanding the risk factors like hypertension in RT is important for patient prognosis and management. A Dahl salt-sensitive (SS) female rat model was used to study hypertension effect on RT-induced cardiotoxicity. Rats were fed a high-salt diet to induce hypertension and then divided into RT and sham groups. The RT group received 24 Gy of whole-heart irradiation. Cardiac function was evaluated using MRI and blood pressure measurements at baseline, 8 weeks and 12 weeks post-RT. Histological examination was performed after the last timepoint or animal death. The hypertensive RT rats demonstrated significant decreases in left-ventricular ejection fraction (EF) (45 ± 7.2%) compared to sham (68 ± 7.3%). Furthermore, circumferential (Ecc) and radial (Err) myocardial strains were significantly reduced (Ecc: −7.4 ± 2.0% RT rats vs. −11 ± 2.4% sham; Err: 15 ± 6.5% RT rats vs. 23 ± 8.9% sham). Histological analysis revealed significant pathophysiological remodeling post-RT, including nuclear size, interstitial fibrosis, necrosis, and the presence of inflammatory cells. This study provides valuable insights into the cardiotoxic effects of RT in the context of hypertension, highlighting the potential of using MRI for improved risk assessment with potential for future clinical translation.